Showing results (521-530 of 569) with videos related to
Sort By:
Pageof 57
Epidemiology and Infection|July 14, 2006
Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infectionL J Brant, M Hurrelle, M A Balogun, et al.Journal of the American College of Cardiology|February 9, 2018
Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and StrokeMichael V Holmes, Iona Y Millwood, Christiana Kartsonaki, et al.Plos One|June 19, 2013
Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2M Cris Silva-Santisteban, Isaac M Westwood, Kathy Boxall, et al.Journal of Medicinal Chemistry|November 8, 2013
Aurora isoform selectivity: design and synthesis of imidazo[4,5-b]pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cellsVassilios Bavetsias, Amir Faisal, Simon Crumpler, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2017
Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006A Gilsdorf, N Boxall, V Gasimov, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 8, 2006
Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006A Gilsdorf, N Boxall, V Gasimov, et al.Journal of Medicinal Chemistry|October 23, 2012
Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitorsMichael Lainchbury, Thomas P Matthews, Tatiana McHardy, et al.European Journal of Preventive Cardiology|January 10, 2024
PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populationsMichael V Holmes, Christiana Kartsonaki, Ruth Boxall, et al.Oncotarget|September 28, 2013
The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug designSylvain Couty, Isaac M Westwood, Andrew Kalusa, et al.Science Translational Medicine|June 26, 2020
Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human geneticsJonas Bovijn, Kristi Krebs, Chia-Yen Chen, et al.Pageof 57